ARMP (Armata Pharmaceuticals, Inc.) יתרות המזומנים של החברה

סמל תאגידי ולוגו של Armata Pharmaceuticals (ARMP)

Armata Pharmaceuticals (ARMP) adheres to basic environmental standards when disposing of laboratory reagents. The company is developing breakthrough methods to combat superbugs by investing in overcoming antibiotic resistance. The cash balance on the balance sheet demonstrates financial stability, where 0.02 represents the current level of the metric. Developments are protected by strain patents, although strict biocontrol and formula complexity limit market access.

ARMP - היקף יתרות המזומנים של החברה Armata בטווח 04.07.2022 - 21.11.2026

פילוחים אנליטיים של חברת Armata Pharmaceuticals

- שווי מניות ותחזית קונצנזוס למחירים:
- פרטי פוזיציית מזומנים ותזרימי מזומנים:
הערכת שווי פונדמנטלית:ARMP Armata Pharma
פריט של המותג Armata Pharmaceuticals Inc

Amid uncertainty, investors prioritize capital preservation through liquidity analysis. This metric aggregates balances across all settlement accounts, determining the business's degree of autonomy from external borrowings. By analyzing current cash holdings, one can identify an excessive accumulation of non-working assets. For Armata Pharmaceuticals (ARMP), this reserve is critical, as the absence of commercial revenue from bacteriophage development makes cash the sole resource until the completion of clinical stages.

ניתוח מתחרים של Armata Pharmaceuticals